{"title":"The Influence of Unsaturated Fatty Acids for Atherosclerosis in Recent Years","authors":"M. Bando, H. Bando","doi":"10.33805/2638-812X.110","DOIUrl":null,"url":null,"abstract":"There have been various discussions of Monounsaturated Fatty Acids (MUFA) and Polyunsaturated Fatty Acids (PUFA) for influencing atherosclerosis. MUFA seems to have beneficial effects on the risk of coronary heart disease and atherosclerosis [1], and the authors have reported the marine-derived long-chain MUFA decrease atherosclerosis lesion development and total cholesterol in mouse [2]. \nOn contrast, n-3 PUFA has been studied by GISSI-P trial, which was the Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’lnfarto Miocardio-Prevenzione (GISSI-P) Trial [3]. \n\nIt included 11,324 subjects who had myocardial infarction followed up for 3.5 years. Administration of n-3 PUFA significantly lowered the risk of primary endpoint by 10%, suggesting beneficial effect statistically. Consecutive study showed the clinical effects for death, combined death, stroke and non-fatal myocardial infarction. Furthermore, it attributed the reduced risk of the events for overall by 20%, cardiovascular by 30%, and sudden death by 45% [4].","PeriodicalId":73168,"journal":{"name":"Global journal of obesity, diabetes and metabolic syndrome","volume":"45 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal of obesity, diabetes and metabolic syndrome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33805/2638-812X.110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
There have been various discussions of Monounsaturated Fatty Acids (MUFA) and Polyunsaturated Fatty Acids (PUFA) for influencing atherosclerosis. MUFA seems to have beneficial effects on the risk of coronary heart disease and atherosclerosis [1], and the authors have reported the marine-derived long-chain MUFA decrease atherosclerosis lesion development and total cholesterol in mouse [2].
On contrast, n-3 PUFA has been studied by GISSI-P trial, which was the Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’lnfarto Miocardio-Prevenzione (GISSI-P) Trial [3].
It included 11,324 subjects who had myocardial infarction followed up for 3.5 years. Administration of n-3 PUFA significantly lowered the risk of primary endpoint by 10%, suggesting beneficial effect statistically. Consecutive study showed the clinical effects for death, combined death, stroke and non-fatal myocardial infarction. Furthermore, it attributed the reduced risk of the events for overall by 20%, cardiovascular by 30%, and sudden death by 45% [4].
关于单不饱和脂肪酸(MUFA)和多不饱和脂肪酸(PUFA)对动脉粥样硬化的影响有各种各样的讨论。MUFA似乎对冠心病和动脉粥样硬化[1]的风险有有益的影响,作者已经报道了海洋来源的长链MUFA可以降低小鼠[1]动脉粥样硬化病变的发展和总胆固醇。相比之下,n-3 PUFA已通过gisisp试验进行了研究,该试验是Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell ' infarto micardio - preventzione (gisisp) trial[3]。该研究包括11324名心肌梗死患者,随访时间为3.5年。给予n-3 PUFA可显著降低10%的主要终点风险,统计学上显示有益效果。连续研究显示了对死亡、合并死亡、中风和非致死性心肌梗死的临床效果。此外,该研究还将这些事件的总体风险降低了20%,心血管疾病风险降低了30%,猝死风险降低了45%。